By The SUN
The inflammation of the heart happened after the youngsters got their second BioNTech jab |
No new case of Covid-19 was reported today, Sept 16, the
second time this month that zero infection was reported in
The city’s total Covid-19 tally stands at 12,149 confirmed cases and one probable case.
Meanwhile, an expert panel that advises the government on its vaccination program has recommended that adolescents aged between 12 and 17 should just get one dose of the BioNTech vaccine instead of two.
Call us! |
The shift comes after more than 30 teenagers reportedly suffered inflammation of the heart, mostly after the second dose, since the government started giving them BioNTech jabs from June. The ailment, known as Myopericarditis, is suspected to be a side effect of the vaccine.
Professor Lau Yu-lung, who chairs one of two scientific committees on the vaccination program, said the statistics showed the side effect was more prevalent than originally thought.
Because of this, it would be better if teenagers got only one dose to reduce the chance of heart inflammation.
CONTACT US! |
He also said that getting the first jab should be enough
protection to youngsters, given that
Lau said the advice strikes a balance between the vaccine’s risk and benefits.
“At the time the decision was made based on the best available evidence. If you view it in this context, obviously it was not a mistake at that time to recommend two doses,” he said.
Tunghayan ang isa na namang kwentong Dream Love |
"But if you use the current understanding in the context of Hong Kong… we need to have the courage to come out to the public and do the proper risk communication that we’re going to switch from two doses to one dose.”
The experts also recommended doing intramuscular injection of the BioNTech vaccine at mid-thigh, especially for children and adolescents.
But Lau said that if the teenagers are going to study abroad,
particularly in Europe or the
More elderly people need to be vaccinated before the borders are opened say the experts |
During the meeting, the experts also agreed that they need more information on whether a booster is shot is needed for everyone, particularly the immunocompromised, before making a decision.
They reviewed all the latest scientific evidence and
concluded that the two Covid-19 vaccines used in
Panel member David Hui said another factor they needed to consider was when
“Currently, we’re doing fine. There’re no cases. But when do we need to live
with the virus? We need to be guided,” he said.
But before opening its borders,
Hui noted that vaccine coverage remains low, in particular among those who live in residential care homes.
Vaccination for this group of people should be done as soon as possible, as long as they are not suffering from acute illnesses, said the experts.
Details of the interim recommendations are available at the CHP's website: www.chp.gov.hk/en/static/24008.html.
|